Information sourced from NEJM Journal Watch:
Managing Seasonal Allergic Rhinitis with Medications
Updated guidelines from the 2017 Joint Task Force on Practice Parameters recommend initial treatment with an intranasal corticosteroid alone.
Sponsoring Organizations: American Academy of Allergy, Asthma, and Immunology (AAAAI); American College of Allergy, Asthma, and Immunology (ACAAI)
Target Audience: Primary care providers, otolaryngologists, allergists, and pulmonologists
Seasonal allergic rhinitis affects as many as 14% of adults in the U.S. Most patients either self-treat or see primary care clinicians; only a minority of patients see allergists. Patients and physicians alike often express confusion about the best medication or combination of medications to use. This update of a 2008 guideline from the AAAAI and ACAAI provides specific guidance on pharmacologic treatment for seasonal allergic rhinitis, including for initial therapy.
Patients tend to prefer oral medications over nasal sprays, but if an intranasal corticosteroid is used regularly, it is the most effective medication for addressing all allergic rhinitis symptoms, with no need to add an oral antihistamine. However, because many patients seem to feel better while taking oral antihistamines, I suggest using them only as needed and stressing daily use of their nasal steroid. For patients with mild nasal symptoms (especially mild itching, rhinorrhea, or sneezing) or systemic itching or urticaria, an oral antihistamine is appropriate first-line therapy. For patients whose allergic rhinitis is not controlled adequately with intranasal corticosteroids alone or who have severe symptoms and want quicker onset of action, intranasal antihistamines such as azelastine can be added to their nasal steroid, albeit at the expense of dysgeusia.
David J. Amrol, MD reviewing Wallace DV et al. Ann Intern Med 2017 Nov 28.
Wallace DV et al. Pharmacologic treatment of seasonal allergic rhinitis: Synopsis of guidance from the 2017 Joint Task Force on Practice Parameters. Ann Intern Med 2017 Nov 28; [e-pub].
NEJM Journal Watch is produced by NEJM Group, a division of the Massachusetts Medical Society. Copyright ©2017 Massachusetts Medical Society. All rights reserved.
The above message comes from NEJM Journal Watch, who is solely responsible for its content.